Romanelli Joseph's Form 4 filing

Merck & Co., Inc. (MRK) · filed Jun 30, 2023

Accession no.: 0001127602-23-019612
Filed: Jun 30, 2023
Trade date: Dec 2, 2022-Apr 26, 2023
Filing delay: 210 daysLate
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market purchases total $44.3K. Open-market sales total $3.66K. It was filed 210 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Romanelli JosephCIK 0001938322	Officer (President, Human Health Int?l)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership
Dec 2, 2022	Common Stock	PPurchaseAcquired	+59	$109.67	+$6,470.53	59	Indirect
Dec 5, 2022	Common Stock	PPurchaseAcquired	+107	$109.54	+$11,720.78	20,391.33	Direct
Dec 6, 2022	Common Stock	PPurchaseAcquired	+30	$109.39	+$3,281.7	20,421.33	Direct
Dec 13, 2022	Common Stock	PPurchaseAcquired	+56	$110.96	+$6,213.76	20,477.33	Direct
Dec 19, 2022	Common Stock	PPurchaseAcquired	+7	$109.04	+$763.28	20,484.33	Direct
Feb 21, 2023	Common Stock	PPurchaseAcquired	+11	$109.20	+$1,201.2	20,495.33	Direct
Mar 20, 2023	Common Stock	PPurchaseAcquired	+136	$105.47	+$14,343.92	20,631.33	Direct
Mar 24, 2023	Common Stock	SSaleDisposed	−35	$104.65	−$3,662.75	20,596.33	Direct
Apr 26, 2023	Common Stock	PPurchaseAcquired	+3	$113.68	+$341.04	20,599.33	Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)